Effect of Lamivudine on Human T-Cell Leukemia Virus Type 1 (HTLV-1) DNA Copy Number, T-Cell Phenotype, and Anti-Tax Cytotoxic T-Cell Frequency in Patients with HTLV-1-Associated Myelopathy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (32)
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
1995 • 8,575 citations
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
1985 • 2,840 citations
Adult T-cell leukemia: clinical and hematologic features of 16 cases
1977 • 2,119 citations
Adult T-cell leukemia: clinical and hematologic features of 16 cases
1977 • 1,750 citations
Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.
1983 • 1,555 citations
A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
1995 • 820 citations
Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp
1998 • 678 citations
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease
1990 • 603 citations
Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)
1995 • 524 citations
Virus diseases of man
1948 • 339 citations
In vivo estimates of division and death rates of human T lymphocytes.
1995 • 276 citations
Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidine
1986 • 245 citations
Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.
1995 • 187 citations
Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission
1994 • 172 citations
3'-Azido-3'-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS.
1987 • 137 citations
Evaluation of Safety and Efficacy of 3TC (Lamivudine) in Patients with Asymptomatic or Mildly Symptomatic Human Immunodeficiency Virus Infection: A Phase I/II Study
1995 • 131 citations
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial
1997 • 118 citations
Clonal Expansion of Infected Cells: A Way of Life for HTLV-I
1996 • 109 citations
The dynamics of HTLV-I and the CTL response
1999 • 94 citations
The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis
1994 • 89 citations
High Activated and Memory Cytotoxic T-cell Responses to HTLV-1 in Healthy Carriers and Patients with Tropical Spastic Paraparesis
1996 • 83 citations
Prospective Study of HTLV-I Infection in an Initially Asymptomatic Cohort
1999 • 82 citations
Immediate effects of reversible HTLV-ITax function: T-cell activation and apoptosis
1995 • 81 citations
Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM.
1996 • 75 citations
Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I.
1987 • 65 citations
AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro.
1997 • 63 citations
High‐dose zidovudine induction in HTLV‐I‐associated myelopathy
1993 • 56 citations
Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbits
1990 • 41 citations
HTLV-1 Infection in Tropical Spastic Paraparesis: Lymphocyte Culture and Serologic Response
1988 • 40 citations
Quantification of proviral DNA load in human T-cell leukaemia virus type I infections
1998 • 38 citations
Increased Expression of Interleukin-2 Receptor α on Peripheral Blood Mononuclear Cells in HTLV-I tax/rex mRNA–Positive Asymptomatic Carriers
1997 • 26 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database